SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-214933
Filing Date
2020-08-10
Accepted
2020-08-10 16:16:32
Documents
5
Effectiveness Date
2020-08-10

Document Format Files

Seq Description Document Type Size
1 S-8 d46156ds8.htm S-8 82923
2 EX-5.1 d46156dex51.htm EX-5.1 9840
3 EX-23.2 d46156dex232.htm EX-23.2 1954
4 GRAPHIC g46156ex511.jpg GRAPHIC 2273
5 GRAPHIC g46156ex512.jpg GRAPHIC 1140
  Complete submission text file 0001193125-20-214933.txt   100778
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-243716 | Film No.: 201089584
SIC: 2834 Pharmaceutical Preparations